Biltmore Wealth Management, LLC Pfizer Inc Transaction History

Biltmore Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 08, 2019	SELL	$37.5 - $41.2 $711,487 - $781,687	-18,973 Closed	0 $0
Q4 2018 Jan 14, 2019	SELL	$38.47 - $43.86 $11,810 - $13,465	-307 Reduced 1.59%	18,973 $828,000
Q3 2018 Oct 10, 2018	SELL	$34.47 - $41.81 $80,108 - $97,166	-2,324 Reduced 10.76%	19,280 $850,000
Q2 2018 Jul 19, 2018	BUY	$32.98 - $35.16 $57,912 - $61,740	1,756 Added 8.85%	21,604 $784,000
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $12,093 - $14,030	-379 Reduced 1.87%	19,848 $704,000
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $13,969 - $14,821	420 Added 2.12%	20,227 $733,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $614,017 - $676,409	19,807	19,807 $707,000

3,216

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Biltmore Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Biltmore Wealth Management, LLC with notifications on news.